Aiforia Technologies Oyj (AIFORIA.HE)
Helsinki · EUR · Healthcare · Health Information Services
€0.852 (+0.59%) as of
Key statistics
- Market cap
- 31.88M
- Forward P/E
- -2.79
- EPS (TTM)
- -0.4200
- Dividend yield
- 0.00%
- 52-week range
- 0.8310 – 2.9300
- Beta
- 0.12
- Revenue (TTM)
- 2.89M
- Profit margin
- 0.00%
- Analyst target
- €1.05
- Volume
- 19.73k
About Aiforia Technologies Oyj
Aiforia Technologies Oyj, together with its subsidiary, Aiforia Inc., provides AI-based image analysis software used in clinical, preclinical, and academic laboratories to pathologists and researchers in Finland, rest of Europe, North America, and internationally. It offers tools for AI-supported diagnostics and visualization of patient samples, as well as automated screening and reporting tools for the treatment of various cancers, such as breast, lung, and prostate cancer; CE-IVD marked Aiforia clinical suite viewer for the clinical pathology workflow; and Aiforia Create, an agile solution to develop an AI model for image analysis application. The company's products are used for the treatment of Parkinson's disease, organ transplantation, and liver and inflammatory bowel diseases. The company serves academic institutes and pharmaceutical companies through direct and sales partners. Aiforia Technologies Oyj was incorporated in 2013 and is headquartered in Helsinki, Finland.
- Sector
- Healthcare
- Industry
- Health Information Services
- Headquarters
- Helsinki, Finland
- Employees
- 67
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.